Abstract
Purpose
Reoperations (R-PTX) for primary hyperparathyroidism (pHPT) are challenging, since they are associated with increased failure and morbidity rates. The aim was to evaluate the results of reoperations over two decades, the latter considering the implementation of Tc99msestamibi-SPECT (Mibi/SPECT), intraoperative parathormone (IOPTH) measurement, and intraoperative neuromonitoring (IONM).
Patients and methods
Data of 1,363 patients who underwent surgery for pHPT were retrospectively analyzed regarding reoperations. Causes of persistent (p) pHPT or recurrent (r) pHPT, preoperative imaging studies, surgical findings, and outcome were analyzed. Data of patients who underwent surgery between 1987 and 1997 (group 1; G1) and between 1998 and 2008 (group 2; G2) with the use of Mibi/SPECT, IOPTH, and IONM were evaluated.
Results
One hundred twenty-five patients with benign ppHPT (n = 108) or rpHPT (n = 17) underwent reoperations (R-PTX). Group 1 included 54, group 2 71 patients. Main cause of ppHPT (G1 = 65 % vs. G2 = 53 %) and rpHPT (G1 = 80 % vs. G2 = 60 %) was the failed detection of a solitary adenoma (p = 0.2). Group 1 patients had significantly less unilateral/focused neck re-explorations (G1 = 23 % vs. G2 = 57 %, p = 0.0001), and more sternotomies (G1 = 35 vs. G2 = 14 %, p = 0.01). After a median follow-up of 4 (range 0.9–23.4) years, reversal of hypercalcemia was achieved in 91 % (G1) and in 98.6 % in group 2 (p = 0.08, OR 7.14 [0.809–63.1]). The rates of permanent recurrent laryngeal nerve palsy (G1 = G2 = 9 %, p = 1) and of postoperative permanent hypoparathyroidism (G1 = 9 % vs. G2 = 6 %, p = 0.5) were not significantly different. Other complications such as wound infection, postoperative bleeding, and pneumonia were significantly lower in group 2 (p < 0.001).
Conclusion
Nowadays, cure rates of R-PTX are nearly the same as in primary operations for pHPT. These results can be achieved in high-volume centers by routine use of well-established preoperative Mibi/SPECT and US in combination with IOPTH. However, morbidity is still considerably high.
Similar content being viewed by others
References
Grant CS, Herden JA, Charboneau JW, James EM, Reading CC (1986) Clinical management of persistent and/or recurrent primary hyperparathyroidism. World J Surg 10:555–565
Akerström G, Rudberg C, Grimelius L, Johannsson H, Lundström B, Rastad J (1992) Causes of failed primary exploration and technical aspects of re-operation in primary hyperparathyroidism. World J Surg 16:562–568
Jaskowiak N, Norton JA, Alexander HR, Doppman JL, Shawker T, Skarulis M, Marx S, Spiegel A, Fraker DL (1986) A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg 224(3):308–320
Karakas E, Zielke A, Dietz C, Rothmund M (2005) Reoperations for primary hyperparathyroidism. Chirurg 76:207–216
Richards ML, Thompson GB, Farley DR, Grant CS (2008) Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring. Am J Surg 196:937–943
Hessman O, Stalberg P, Sundin A, Garske U, Rudberg C, Eriksson L-G, Hellman P, Akerström G (2008) High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 32:774–781
Henry JF, Sebag F, Cherenko M, Ippolito G, Taieb D, Vaillant J (2008) Endoscopic parathyroidectomy: why and when? World J Surg 32:2509–2515
Bergenfelz A, Kanngiesser V, Zielke A, Nies C, Rothmund M (2005) Conventional bilateral cervical exploration versus open minimally invasive parathyroidectomy under local anaesthesia for primary hyperparathyroidism. Br J Surg 92(2):190–197
Udelsman R, Lin Z, Donovan P (2011) The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 253:585–591
Miura D, Wada N, Arici C, Morita E, Duh Q-Y, Clark OH (2002) Does intraoperative parathyroid hormone assay improve the results of parathyroidectomy? World J Surg 26:926–930
Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M (2004) Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 136:872–880
Udelsman R, Aruny JE, Donovan P, Sokoll LJ, Santos F, Donabedian R, Venbrux AC (2002) Rapid parathyroid hormone analysis during venous localization. Ann Surg 237(5):714–721
Reidel MA, Schilling T, Graf S, Hinz U, Nawroth P, Büchler MW, Weber T (2006) Localization of hyperfunctioning parathyroid glands by selective venous sampling in reoperation for primary or secondary hyperparathyroidism. Surgery 140:907–913
Gotthardt M, Lohmann B, Behr TM, Bauhofer A, Franzius C, Schipper ML, Wagner M, Höffken H, Sitter H, Rothmund M, Joseph K, Nies C (2004) Clinical value of parathyroid scintigraphy with technetium-99m methoxybutylisnitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surg 28:100–107
Grant C, Thompson G, Farley D, Heerden JV (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy. Arch Surg 140:472–479
Jaskowiak N, Norton JA, Alexander HR, Doppman JL, Shawker T, Skarulis M, Marx S, Spiegel A, Fraker DL (1996) A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg 224(3):308–320
Brennan MF, Norton JA (1985) Reoperation for persistent and recurrent hyperparathyroidism. Ann Surg 201(1):40–44
Cheung PS, Borgstrom A, Thompson NW (1989) Strategy in reoperative surgery for hyperparathyroidism. Arch Surg 124(6):676–680
Shen W, Duren M, Morita E, Higgins C, Duh QY, Siperstein A, Clark OH (1996) Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg 131(8):861–867
Akerström G, Malmaeus J, Bergström R (1984) Surgical anatomy of human parathyroid glands. Surgery 95:14–21
Van Heerden JA, Grant CS (1991) Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 15(6):688–692
Mitchell J, Milas M, Barbosa G, Sutton J, Berber E, Siperstein A (2008) Avoidable reoperations for thyroid and parathyroid surgery: effect of hospital volume. Surgery 144(5):899–906
Henry JF (2010) Reoperation for primary hyperparathyroidism: tips and tricks. Langenbecks Arch Surg 395:103–109
Sebag F, Shen W, Brunaud L, Kebebew E, Duh QY, Clark OH (2003) Intraoperative parathyroid hormone assay and parathyroid reoperations. Surgery 134:1049–1056
Fayet P, Hoeffel C, Fulla Y, Legmann P, Hazebroucq V, Luton JP, Chapuis Y, Richard B, Bonnin A (1997) Technetium-99m sestamibi scintigraphy, magnetic resonance imaging and venous blood sampling in persistent and recurrent hyperparathyroidism. Brit J Radiol 70:459–464
Jones JJ, Bruneaud L, Dowd CF, Duh QY, Morita E, Clark OH (2002) Accuracy of selective venous sampling for intact parathyroid hormone in difficult patients with recurrent or persistent hyperparathyroidism. Surgery 132:944–951
Irvin GL III, Molinari AS, Figueroa C, Carneiro DM (1999) Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 229:874–879
Powell AC, Alexander HR, Chang R, Marx SJ, Skarulis M, Pingpank JF, Bartlett DL, Hughes M, Weinstein LS, Simonds WF, Collins MF, Shawker T, Chen CC, Reynolds J, Cochran C, Steinberg SM, Libutti SK (2009) Reoperation for parathyroid adenoma: a contemporary experience. Surgery 146:1144–1155
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karakas, E., Müller, HH., Schlosshauer, T. et al. Reoperations for primary hyperparathyroidism—improvement of outcome over two decades. Langenbecks Arch Surg 398, 99–106 (2013). https://doi.org/10.1007/s00423-012-1004-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-012-1004-y